MIST Bathi saben saham sajrone rolas wulan pungkasan Milestone Pharma

The 12-month net income per share trend for Milestone Pharmaceuticals (MIST) highlights the impact of mucosal delivery patents and Phase 3 trial costs. The value of -0.69 reflects the current metric level amid FDA approval risks for the nasal spray and reliance on external capital. Business stability is supported by the expanded application of the lead molecule and global licensing agreements.

Milestone Pharmaceuticals (MIST) - Bathi saben saham sajrone patang kuartal pungkasan saka 04.07.2022 nganti 12.11.2026

Rincian metrik keuangan lan pasar Milestone Pharmaceuticals, Inc. (MIST)

- rega saham lan target rega konsensus:

Rega saham Milestone Pharmaceuticals|MIST - Rata-rata rega prakiraan

- data kapitalisasi pasar:

Nilai pasar Milestone Pharmaceuticals Inc.|MIST - Rega Tumbas Perusahaan

- data nilai buku modal saham:

Nilai Akuntansi saben Saham Milestone Pharmaceuticals|MIST - Total Aset Bersih|Rasio Nilai Pasar marang Nilai Buku milestonepharma.com|MIST - Aset Perusahaan

- indikator beban kredit lan likuiditas emiten:

Utang marang Ekuitas Milestone Pharmaceuticals|MIST - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal Milestone Pharma|MIST - Utang kumulatif perusahaan|Utang marang nilai buku Milestone Pharmaceuticals Inc.|MIST - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Milestone Pharmaceuticals|Rasio cepet milestonepharma.com

- indikator bathi lan kelipatan valuasi:

MIST - Bathi pungkasan|Proyeksi bathi mangsa ngarep Milestone Pharmaceuticals|MIST - Pangali P/E|Rega marang bathi mangsa ngarep Milestone Pharmaceuticals Inc.|MIST - Koefisien bali modal nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Milestone Pharmaceuticals Inc.|MIST - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Milestone Pharmaceuticals|MIST - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan milestonepharma.com|MIST - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Milestone Pharmaceuticals

Analisis dhasar perusahaan:Milestone Pharmaceuticals - MIST

Produk seri Milestone Pharmaceuticals, Inc.

Milestone Pharmaceuticals (MIST) is strengthening its position in emergency cardiology by integrating rhythm-control medications into clinical practice. By analyzing the company's rolling annual earnings per share, an investor can view the net income over 12 months divided by the number of shares, which allows for an assessment of real business efficiency without dilution distortions and helps determine the asset's fair value.

Perusahaan pesaing

Regeneron Pharmaceuticals - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan irhythmtech.com|Lantheus (LNTH) - Bathi saben saham sajrone rolas wulan pungkasan|MLYS - Bathi resik saben saham sajrone patang kuartal pungkasan|Bathi resik saben saham sajrone 12 wulan pungkasan HTFL|KMTS (Kestra Medical Corp) - Bathi saben saham sajrone patang kuartal pungkasan|Bathi saben saham sajrone rolas wulan pungkasan Esperion Therapeutics (ESPR)|AMRN - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Bathi saben saham sajrone rolas wulan pungkasan Anteris Technologies AVR|TNYA: Bathi saben saham sajrone 12 wulan pungkasan|CVRx, Inc - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan Cardiol Therapeutics|BEAT (HeartBeam, Inc.) - Bathi resik saben saham sajrone 12 wulan pungkasan|tenaxthera.com - Bathi saben saham sajroning taun lumaku|Bathi saben saham sajrone rolas wulan pungkasan Adagio Medical|BioCardia Inc. - Bathi saben siji saham sajrone 12 wulan pungkasan|Bathi resik saben saham (EPS TTM) VTAK|ABIO (arcabio.com) - Bathi saben saham sajroning taun lumaku|Bathi resik saben saham (EPS TTM) ACST (Acasti Pharma Inc.)|Bathi resik saben saham (EPS TTM) aerovatetx.com AVTE|VERV - Bathi saben saham sajrone rolas wulan pungkasan|Bathi saben saham sajroning taun lumaku WINT (Windtree Therapeutics)